Joseph E. Tota

1.9k total citations
51 papers, 1.2k citations indexed

About

Joseph E. Tota is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Joseph E. Tota has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 23 papers in Surgery and 10 papers in Oncology. Recurrent topics in Joseph E. Tota's work include Cervical Cancer and HPV Research (39 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (16 papers). Joseph E. Tota is often cited by papers focused on Cervical Cancer and HPV Research (39 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (16 papers). Joseph E. Tota collaborates with scholars based in United States, Canada and Netherlands. Joseph E. Tota's co-authors include Eduardo L. Franco, François Coutlée, L Richardson, Anil K. Chaturvedi, Myriam Chévarie‐Davis, Agnihotram V. Ramanakumar, Alex Ferenczy, Maura L. Gillison, Salaheddin M. Mahmud and Rohit P. Ojha and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Joseph E. Tota

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph E. Tota United States 18 836 421 244 218 162 51 1.2k
Silvia Jiménez United States 17 1.1k 1.3× 575 1.4× 263 1.1× 316 1.4× 167 1.0× 39 1.6k
Dañelle C. Smith United States 15 1.1k 1.3× 775 1.8× 154 0.6× 227 1.0× 117 0.7× 17 1.4k
Antonios Athanasiou Greece 14 1.1k 1.3× 419 1.0× 291 1.2× 52 0.2× 149 0.9× 29 1.4k
Cindy Simoens Belgium 16 1.1k 1.3× 427 1.0× 360 1.5× 35 0.2× 177 1.1× 31 1.5k
Staci L. Sudenga United States 14 719 0.9× 372 0.9× 186 0.8× 90 0.4× 61 0.4× 45 903
Alessandra Latini Italy 19 457 0.5× 303 0.7× 176 0.7× 72 0.3× 112 0.7× 94 1.2k
Jiayao Lei Sweden 11 919 1.1× 278 0.7× 303 1.2× 43 0.2× 173 1.1× 17 1.2k
Anne‐Carole Jacquard France 11 791 0.9× 404 1.0× 106 0.4× 137 0.6× 58 0.4× 14 913
C. David Wrede Australia 20 988 1.2× 294 0.7× 761 3.1× 61 0.3× 336 2.1× 52 1.6k
H. R. Shin South Korea 9 1.0k 1.2× 589 1.4× 239 1.0× 30 0.1× 151 0.9× 12 1.3k

Countries citing papers authored by Joseph E. Tota

Since Specialization
Citations

This map shows the geographic impact of Joseph E. Tota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Tota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Tota more than expected).

Fields of papers citing papers by Joseph E. Tota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Tota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Tota. The network helps show where Joseph E. Tota may publish in the future.

Co-authorship network of co-authors of Joseph E. Tota

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Tota. A scholar is included among the top collaborators of Joseph E. Tota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Tota. Joseph E. Tota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Xuedan, Stefano Valente, Dorothy A. Machalek, et al.. (2025). Epidemiologic, clinical, and economic burden of anogenital warts among adults: A global systematic review. International Journal of Infectious Diseases. 161. 108029–108029.
2.
El‐Zein, Mariam, et al.. (2025). Impact of HPV vaccination on the incidence and clearance of HPV infections in sexually active young women. Vaccine. 63. 127632–127632. 1 indexed citations
3.
Tota, Joseph E., et al.. (2024). Quadrivalent HPV Vaccine Effectiveness Against Cervical Intraepithelial Lesion Grade 2 or Worse in Norway: A Registry-Based Study of 0.9 Million Norwegian Women. The Journal of Infectious Diseases. 230(6). e1202–e1206. 5 indexed citations
4.
El‐Zein, Mariam, Joseph E. Tota, Pierre‐Paul Tellier, et al.. (2024). Use of a carrageenan‐based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men. Journal of Medical Virology. 96(3). e29562–e29562. 1 indexed citations
5.
El‐Zein, Mariam, Joseph E. Tota, Pierre‐Paul Tellier, et al.. (2024). Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. Journal of Medical Virology. 96(4). e29604–e29604. 1 indexed citations
6.
Giuliano, Anna R., Joel M. Palefsky, Stephen E. Goldstone, et al.. (2023). High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men. The Journal of Infectious Diseases. 229(3). 707–718. 6 indexed citations
7.
Wang, Wei, Smita Kothari, Marc Baay, et al.. (2021). Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources. Expert Review of Vaccines. 21(2). 227–240. 9 indexed citations
8.
Tota, Joseph E., et al.. (2021). Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial. Contemporary Clinical Trials. 110. 106560–106560. 8 indexed citations
9.
Tota, Joseph E., Mariam El‐Zein, Ann N. Burchell, et al.. (2018). Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial. Clinical Microbiology and Infection. 25(2). 210–216. 37 indexed citations
10.
Tota, Joseph E., J. Bentley, Jennifer Blake, et al.. (2017). Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Preventive Medicine. 98. 5–14. 82 indexed citations
11.
Tota, Joseph E., J. Bentley, Jennifer Blake, et al.. (2017). Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Preventive Medicine. 98. 15–20. 30 indexed citations
12.
Tota, Joseph E., William F. Anderson, Charles S. Coffey, et al.. (2017). Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012. Oral Oncology. 67. 146–152. 113 indexed citations
13.
Beachler, Daniel C., Joseph E. Tota, Michelle I. Silver, et al.. (2016). Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. 144(2). 391–395. 13 indexed citations
14.
Isidean, Sandra D., et al.. (2014). Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs. Expert Review of Vaccines. 14(1). 119–133. 12 indexed citations
15.
Tota, Joseph E., Agnihotram V. Ramanakumar, Ziad El‐Khatib, & Eduardo L. Franco. (2014). The Road Ahead for Cervical Cancer Prevention and Control. Current Oncology. 21(2). 255–264. 42 indexed citations
16.
Tota, Joseph E., Agnihotram V. Ramanakumar, Joakim Dillner, et al.. (2013). Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination. American Journal of Epidemiology. 178(4). 625–634. 72 indexed citations
17.
18.
Ojha, Rohit P., et al.. (2013). Human Papillomavirus-Associated Subsequent Malignancies among Long-Term Survivors of Pediatric and Young Adult Cancers. PLoS ONE. 8(8). e70349–e70349. 53 indexed citations
19.
Tota, Joseph E., et al.. (2011). Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine. 53. S12–S21. 182 indexed citations
20.
Franco, Eduardo L., Salaheddin M. Mahmud, Joseph E. Tota, Alex Ferenczy, & François Coutlée. (2009). The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change. Archives of Medical Research. 40(6). 478–485. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Jiménez Breakdown of academic impact, for papers by Dañelle C. Smith Breakdown of academic impact, for papers by Antonios Athanasiou Breakdown of academic impact, for papers by Cindy Simoens Breakdown of academic impact, for papers by Staci L. Sudenga Breakdown of academic impact, for papers by Alessandra Latini Breakdown of academic impact, for papers by Jiayao Lei Breakdown of academic impact, for papers by Anne‐Carole Jacquard Breakdown of academic impact, for papers by C. David Wrede Breakdown of academic impact, for papers by H. R. Shin
Rankless by CCL
2026